中文

泰林生物 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-30
ItemAmountY/Y
Revenue¥0.07B+4.7%
Gross profit¥0.04B
Operating income¥0.01B
Net income¥0.00B+45.4%
Gross margin50.3%Net margin 6.9%
Revenue Q/Q-44.5%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.03B49.7%
R&D¥0.01B20.1%
SG&A¥0.02B25.3%
Tax & other¥0.00B0.8%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

中富电路玉禾田艾可蓝双飞集团耐普矿机聚杰微纤英杰电气东岳硅材贝仕达克建科智能北鼎股份阿尔特

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies